JBIO
Price
$14.39
Change
+$0.24 (+1.70%)
Updated
Oct 9 closing price
Capitalization
912.62M
36 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$8.93
Change
+$0.01 (+0.11%)
Updated
Oct 9 closing price
Capitalization
617.86M
32 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

JBIO vs SGMT

JBIO vs SGMT Comparison Chart in %
View a ticker or compare two or three
VS
JBIO vs. SGMT commentary
Oct 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBIO is a Hold and SGMT is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
JBIOSGMT
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
82%
COMPARISON
Comparison
Oct 11, 2026
Stock price -- (JBIO: $14.39 vs. SGMT: $8.93)
Brand notoriety: JBIO and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JBIO: 69% vs. SGMT: 48%
Market capitalization -- JBIO: $912.62M vs. SGMT: $617.86M
JBIO [@Biotechnology] is valued at $912.62M. SGMT’s [@Biotechnology] market capitalization is $617.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JBIO’s FA Score shows that 1 FA rating(s) are green while SGMT’s FA Score has 0 green FA rating(s).

  • JBIO’s FA Score: 1 green, 4 red.
  • SGMT’s FA Score: 0 green, 5 red.
According to our system of comparison, SGMT is a better buy in the long-term than JBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JBIO’s TA Score shows that 5 TA indicator(s) are bullish while SGMT’s TA Score has 3 bullish TA indicator(s).

  • JBIO’s TA Score: 5 bullish, 2 bearish.
  • SGMT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, JBIO is a better buy in the short-term than SGMT.

Price Growth

JBIO (@Biotechnology) experienced а +1.91% price change this week, while SGMT (@Biotechnology) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.51%. For the same industry, the average monthly price growth was -13.43%, and the average quarterly price growth was -4.26%.

Reported Earning Dates

JBIO is expected to report earnings on Nov 16, 2026.

SGMT is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-2.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
JBIO
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APOG40.59-0.18
-0.44%
Apogee Enterprises
WW14.86-0.10
-0.67%
WW International Inc
ZIM29.99-0.27
-0.89%
ZIM Integrated Shipping Services Ltd
PHM112.12-1.41
-1.24%
Pultegroup
AWX2.47-0.11
-4.26%
Avalon Holdings Corp

JBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, JBIO has been loosely correlated with IMNM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if JBIO jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JBIO
1D Price
Change %
JBIO100%
+1.70%
IMNM - JBIO
43%
Loosely correlated
+1.24%
ARVN - JBIO
41%
Loosely correlated
+1.73%
EDIT - JBIO
41%
Loosely correlated
+2.11%
SYRE - JBIO
41%
Loosely correlated
+7.25%
KURA - JBIO
40%
Loosely correlated
+0.76%
More